Zealand Pharma A/S 2022 SR
The report highlights Zealand Pharma's commitment to developing next-generation peptide therapeutics for rare diseases, obesity, type 1 diabetes, and inflammatory diseases. In 2022, the company introduced environmental targets into management bonus awards and focused on employee engagement following an organizational restructure. Key achievements include enhancing gender diversity in corporate management to 33% women and maintaining high employee engagement scores. The company also emphasized its adherence to the UN Sustainable Development Goals and the 3Rs principles for animal welfare.
Company: Zealand Pharma A/S
Sector: Manufacturing
Country: Denmark
Year: 2022
Type: SR
Pages: 17
Back to company
Zealand Pharma A/S
Corporate Responsibility Report
The report highlights Zealand Pharma's commitment to developing next-generation peptide therapeutics for rare diseases, obesity, type 1 diabetes, and inflammatory diseases. In 2022, the company introduced environmental targets into management bonus awards and focused on employee engagement following an organizational restructure. Key achievements include enhancing gender diversity in corporate management to 33% women and maintaining high employee engagement scores. The company also emphasized its adherence to the UN Sustainable Development Goals and the 3Rs principles for animal welfare.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees